AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Ra Pharmaceuticals to Present at Upcoming Investor Conferences

May 28, 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 28, 2019--

Ra Pharmaceuticals, Inc. (Nasdaq: RARX) today announced that senior management will present at the following upcoming investor conferences:

The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of each presentation will be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190528005175/en/

CONTACT: Investors:

Ra Pharmaceuticals

Natalie Wildenradt, 617-674-9874

nwildenradt@rapharma.comMedia:

Argot Partners

David Rosen, 212-600-1902

david.rosen@argotpartners.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE MANAGED CARE

SOURCE: Ra Pharmaceuticals, Inc.

Copyright Business Wire 2019.

PUB: 05/28/2019 07:00 AM/DISC: 05/28/2019 07:01 AM

http://www.businesswire.com/news/home/20190528005175/en

All contents © copyright 2019 The Associated Press. All rights reserved.